Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/15/15 → 10/14/19 |
Funding
- Vertex Pharmaceuticals Incorporated: $96,906.38
A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatmetn with BX-661 in Combination with Ivacaftor in Subjects Aged 12 Years and Older with Cystic Fibrosis,
- Frederick, Carla (PI)
Project: Research